Mandate

Vinge advises Industrifonden and ACTIVE Venture Partners in connection with Barnebys.se investment

October 09, 2012

Vinge has advised Industrifonden and ACTIVE Venture Partners in connection with their total investment of MSEK 9 in Barnebys.se, a search engine for auctions. The capital contribution will primarily be used for international expansion, starting with the UK as well as for continued business development.

Industrifonden invests in small and medium-sized companies with international growth potential. The fund has assets of SEK 3.6 billion and has invested in approximately 90 companies within the technology, cleantech, life science and industrial sectors.

ACTIVE Venture Partners is a European venture capital firm helping technology companies in the start-up and expansion phases of their development. The firm was founded in 2002 and has its registered office in Barcelona. ACTIVE currently manages two funds with a total value of EUR 75 million.

Vinge’s team primarily consisted of partner Johan Larsson and associate Nicolina Kindblom.

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025